Grégoire, M. | IICIMED

Grégoire, M.

Professeur – Praticien Hospitalier

Publications

P42

Eur. J. Immunol. 2005, 35, 546-56. 

A new  carboxamide compound exerts immuno-suppressive activity by inhibiting dendritic cell maturation.

Carbonnelle, D. | Ebstein, F. | Rabu, C. | Petit, J-Y. | Grégoire, M. | Lang, F.

Autres publications scientifiques

PS30

Pediart Infect Dis J 2023, 42(10):888-892.

Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series Analysis.

Cailles, A. | Martin-Perceval, L. | Crémet, L. | Gély, L. | Ruellan, A.-L. | Verdier, M.-C. | Grégoire, M. | Flamant, C. | Guillouzouic, A. | Prot-Labarthe, S. | Butin, M. | Launay, E.

PS29

J Antimicrob Chemother 2023, 78(3):853-854.

Comment on Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.

Benaboud, S. | Solas, C. | Bouchet, S. | Grégoire, M. | Lemaitre, F. | Venisse, N. | Lê, M. | Muret, P. | Parant, F. | Néant, N. | Boujaafar, S. | Lagoutte-Renosi, J. | Garraffo, R. | Peytavin, G.

https://doi.org/10.1093/jac/dkad009

PS28

J Antimicrob Chemother 2023, 78(12):2919-2925.

Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.

Hervochon, C. | Hennart, B. | Leroy, A.-G. | Corvec, S. | Boutoille, D. | Senneville, E. | Sotto, A. | Illes, G. | Chavanet, P. | Dubée, V. | Bleibtreu, A. | De Carné, M.-C. | Talarmin, J.-P. | Revest, M. | Castan, B. | Bellouard, R. | Dailly, E. | Allorge, D. | Dinh, A. | Le Turnier, P. | Grégoire, M.

https://doi.org/10.1093/jac/dkad331

PS27

Int J Antimicrob Agents 2023, 62(5):106960.

Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel.

Senneville, E. | Cuervo, G. | Grégoire, M. | Hidalgo-Tenorio, C. | Jehl, F. | Miro, J.-M. | Seaton, A. | Söderquist, B. | Soriano, A. | Thalhammer, F. | Pea, F.

https://doi.org/10.1016/j.ijantimicag.2023.106960

PS26

Br J Clin Pharmacol 2023.

Therapeutic drug monitoring and virological response at week 48 in a cohort ofHIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER Study). 

Lemaitre, F. | Lagoutte-Renosi, J. | Gagnieu, M.-C. | Parant, F. | Venisse, N. | Grégoire, M. | Bouchet, S. | Garraffo, R. | Lê, M.-P. | Muret, P. | Comets, E. | Solas, C. | Peytavin, G.

https://doi.org/10.1111/bcp.15890

PS25

J Antimicrob Chemother 2023, dkad094.

A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections—a monocentre quality improvement project.

Lagarde, C. | Bouras, M. | Le Floch, R. | Hourmant, Y. | Grillot, N. | Bourdiol, A. | Mahé, P.-J. | Deumeure Dit Latte, D. | Grégoire, M. | Dailly, E. | Bellouard, R. | Asehnoune, K. | Cinotti, R. | Roquilly, A.

https://doi.org/10.1093/jac/dkad094

PS24

J Antimicrob Chemother 2023, 8, 965-974.

Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis.

Bellouard, R. | Rambaud, A. | Delaunay, C. | Dailly, E. | Lecomte, R. | Deschanvres, C. | Leroy, A.-G. | Boutoille, D. | Le Turnier, P. | Grégoire, M.

https://doi.org/10.1093/jac/dkad030

PS23

Antibiotics 2023, 12, 123.

Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach.

Coste, A. | Bellouard, R. | Deslandes, G. | Jalin, L. | Roger, C. | Ansart, S. | Dailly, E. | Bretonnière, C. | Grégoire, M.

https://doi.org/10.3390/antibiotics12010123

PS07

Antimicrob. Agents Chemother. 2022, 66, e0156321.

Highly conserved gsc1 gene of Pneumocystis jirovecii in patients with or without prior exposure to ehinocandins.

Bonnet, P. L. | Le Gal, S. | Hoffmann, C. V. | Morio, F. | Diabira, F. | de Quélen, A. | Curral, G. | Negri, S. | Cogulet, V. | Huon, J.-F. | Grégoire, M. | Papon, N. | Le Pape, P. | Bouchara, J.-P. | Nevez, G.

https://doi.org/10.1128/AAC.01563-21

Brevets

Thèse